The House Energy and Commerce Health Subcommittee today opened a two-day hearing on 25 bills designed to address the opioid crisis. Witnesses from the Food and Drug Administration, the Centers for Disease Control and Prevention, and the Substance Abuse and Mental Health Services Administration outlined steps their agencies are taking to address the epidemic. Witnesses from The Kennedy Forum, Community Anti-Drug Coalitions of America, Biotechnology Innovation Organization, Association for Accessible Medicines, and DisposeRx also testified. AHA is weighing in on the bills with the committee. Chairmen of the relevant committees in Congress have said they hope to enact comprehensive legislation by Memorial Day. The subcommittee hearing will continue tomorrow with testimony from additional witnesses. 

Related News Articles

Headline
The Health Resources and Services Administration yesterday awarded 120 organizations, including hospitals, $200,000 each to develop community partnerships and…
Headline
Laws that allow pharmacists to dispense the opioid antidote naloxone without a physician’s prescription are associated with a sharp reduction in fatal opioid-…
Headline
The White House Office of National Drug Control Policy seeks by 2022 to reduce drug overdose deaths and youth illicit drug use by 15 percent and opioid…
Perspective
Investing in our country’s health infrastructure is the right move to make.
Headline
The AHA yesterday announced support for the Opioid Workforce Act of 2019, bipartisan legislation to reduce the nation’s shortage of opioid treatment providers…
Headline
The National Academy of Medicine Action Collaborative on Countering the U.S. Opioid Epidemic, of which the AHA is a sponsor, held a two-day meeting this week…